Free Trial

82,023 Shares in Maximus, Inc. $MMS Purchased by Public Sector Pension Investment Board

Maximus logo with Business Services background

Key Points

  • The Public Sector Pension Investment Board invested approximately $5.59 million in Maximus, Inc. during the first quarter, acquiring 82,023 shares and holding a total of 0.14% of the company.
  • Maximus recently reported earnings of $2.16 per share, significantly exceeding analyst expectations, and achieved revenue of $1.35 billion for the quarter.
  • The company has declared a quarterly dividend of $0.30 per share, with an annual yield of 1.4%, to be paid on August 31st.
  • Want stock alerts on Maximus? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Public Sector Pension Investment Board acquired a new stake in Maximus, Inc. (NYSE:MMS - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 82,023 shares of the health services provider's stock, valued at approximately $5,593,000. Public Sector Pension Investment Board owned approximately 0.14% of Maximus as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. UMB Bank n.a. grew its position in Maximus by 70.2% in the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after acquiring an additional 250 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Maximus by 67.1% during the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after buying an additional 294 shares during the last quarter. NBC Securities Inc. boosted its stake in shares of Maximus by 114,900.0% during the 1st quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock valued at $78,000 after buying an additional 1,149 shares during the last quarter. Blue Trust Inc. boosted its stake in shares of Maximus by 32.8% during the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after buying an additional 303 shares during the last quarter. Finally, LRI Investments LLC boosted its stake in shares of Maximus by 44.1% during the 4th quarter. LRI Investments LLC now owns 1,638 shares of the health services provider's stock valued at $122,000 after buying an additional 501 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th. One research analyst has rated the stock with a Buy rating, According to MarketBeat, Maximus has an average rating of "Buy" and an average target price of $90.00.

Read Our Latest Stock Analysis on Maximus

Insider Transactions at Maximus

In related news, Director Gayathri Rajan sold 7,913 shares of Maximus stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the transaction, the director directly owned 14,205 shares of the company's stock, valued at $1,028,157.90. The trade was a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is currently owned by insiders.

Maximus Stock Performance

NYSE:MMS traded up $0.0640 during mid-day trading on Thursday, hitting $85.3340. The stock had a trading volume of 125,558 shares, compared to its average volume of 568,503. The stock has a market capitalization of $4.81 billion, a price-to-earnings ratio of 15.70 and a beta of 0.60. The company has a 50 day simple moving average of $73.88 and a 200-day simple moving average of $70.93. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.94. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.77. The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. Maximus's quarterly revenue was up 2.5% compared to the same quarter last year. During the same period last year, the firm posted $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, August 15th. Maximus's dividend payout ratio (DPR) is 22.10%.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Further Reading

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines